Selected Publications & PatentsWho We Are / News / Publications & Patents / Selected Publications & Patents Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, Joyce MA, Milowsky M, Nanus DM, Goldsmith SJ. Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol. 2003; 170:1717-1721. PDF (3.06 MB) Safety & Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma PDF (2.24 MB) Production of bispecific molecules using polyethylene glycol linkers External Link BISPECIFIC MOLECULE COMPRISING AN ANTI-CR1 ANTIBODY CROSS-LINKED TO AN ANTIGEN-BINDING ANTIBODY FRAGMENT External Link Portillo S. Aspyrian’s Photoimmunotherapy Based on the IRDye 700Dx Platform Shows Efficacy in a Number of Studies. ADC Review / J of Antibody-Drug Conjugates. October, 2015. PDF (373.74 KB) Klein M, Lotem M, Peretz T, et al. Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma. Journal of Skin Cancer. Vol. 2013; Article ID 828329, 8 pages, 2013. doi:10.1155/2013/828329. PDF (2.24 MB) Vallabhajosula S, Kuji I, Hamacher KA, Konishi S, Kostakoglu L, Kothari PA, Milowski MI, Nanus DM, Bander NH, Goldsmith SJ. Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: Prediction of 90Y-J591 radiation dosimetry based on 111In or 177LU? J Nucl Med. 2005; 46(4):634-641. PDF (7.17 MB) Leslie Casey, Stanford Lihsyng Lee, Nehal Mohamed, P. James Porter, Muctarr A. Sesay, Xiaoliang Wang. Production of bispecific molecules using polyethylene glycol linkers. US20060153839, WO2004024889 A2, WO2004024889 A3, EP1539811 A2 and EP1539811 A4. External Link genome